Terms: = Breast cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
1955 results:
1. Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of breast cancer-Associated Germline Pathogenic Variants in Mexico.
Mesa-Chavez F; Chavarri-Guerra Y; Aguilar-Y-Mendez D; Becerril-Gaitan A; Vaca-Cartagena BF; Carrillo-Bedoya A; Santiesteban-González S; Aranda-Gutierrez A; Rodríguez-Faure A; Obregon-Leal D; Quintero-Beuló G; Rodriguez-Olivares JL; Miaja M; Weitzel JN; Villarreal-Garza C
JCO Glob Oncol; 2024 Apr; 10():e2300417. PubMed ID: 38635940
[TBL] [Abstract] [Full Text] [Related]
2. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
Salaün H; Djerroudi L; Haik L; Schnitzler A; Bataillon G; Deniziaut G; Bièche I; Vincent-Salomon A; Debled M; Cottu P
J Pathol Clin Res; 2024 May; 10(3):e12372. PubMed ID: 38563252
[TBL] [Abstract] [Full Text] [Related]
3. Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer.
Browne IM; André F; Chandarlapaty S; Carey LA; Turner NC
Lancet Oncol; 2024 Apr; 25(4):e139-e151. PubMed ID: 38547898
[TBL] [Abstract] [Full Text] [Related]
4. Knowledge Mapping of Cowden Syndrome: a Bibliometric Analysis.
Peng Q; Duan N; Wang X; Wang WM
Chin J Dent Res; 2024 Mar; 27(1):75-82. PubMed ID: 38546522
[TBL] [Abstract] [Full Text] [Related]
5. Integrative Bioinformatics Analysis Reveals Potential Target Genes and pten Signaling in breast cancer and Effect of Zingiber officinale (Ginger) and Allium sativum (Garlic) extract on It.
Sheybatzadeh K; Moshtaghie SAA; Shahanipour K; Golab F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):893-908. PubMed ID: 38546072
[TBL] [Abstract] [Full Text] [Related]
6. Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the pten/PI3K/AKT/NF-κB pathway.
Kim MJ; Lim SG; Cho DH; Lee JY; Suk K; Lee WH
Biochem Biophys Res Commun; 2024 May; 709():149828. PubMed ID: 38537596
[TBL] [Abstract] [Full Text] [Related]
7. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative breast cancer Subtypes.
Basho RK; Zhao L; White JB; Huo L; Bassett RL; Mittendorf EA; Thompson A; Litton JK; Ueno N; Arun B; Lim B; Valero V; Tripathy D; Zhang J; Adrada BE; Santiago L; Ravenberg E; Seth S; Yam C; Moulder SL; Damodaran S
JCO Precis Oncol; 2024 Mar; 8():e2300124. PubMed ID: 38484209
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
10. eEF1A2 promotes pten-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.
Treekitkarnmongkol W; Solis LM; Sankaran D; Gagea M; Singh PK; Mistry R; Nguyen T; Kai K; Liu J; Sasai K; Jitsumori Y; Liu J; Nagao N; Stossi F; Mancini MA; Wistuba II; Thompson AM; Lee JM; Cadiñanos J; Wong KK; Abbott CM; Sahin AA; Liu S; Katayama H; Sen S
Sci Signal; 2024 Mar; 17(826):eadh4475. PubMed ID: 38442201
[TBL] [Abstract] [Full Text] [Related]
11. Best of the year: Advanced breast cancer in 2023.
Schlam I; Chavez-MacGregor M
Breast; 2024 Apr; 74():103677. PubMed ID: 38401422
[TBL] [Abstract] [Full Text] [Related]
12. The interplay of pten and AKT nexus in breast cancer: a molecular perspective.
Kamal A; Awan AR; Rabbani M; Sheikh HR; Tayyab M; Firyal S; Khan IH; Wasim M
Mol Biol Rep; 2024 Feb; 51(1):345. PubMed ID: 38400870
[TBL] [Abstract] [Full Text] [Related]
13.
Tanaka H; Motooka Y; Maeda Y; Sonehara R; Nakamura T; Kajiyama H; Mashimo T; Toyokuni S
Free Radic Res; 2024 Feb; 58(2):130-143. PubMed ID: 38394084
[TBL] [Abstract] [Full Text] [Related]
14. Capivasertib: First Approval.
Shirley M
Drugs; 2024 Mar; 84(3):337-346. PubMed ID: 38388873
[TBL] [Abstract] [Full Text] [Related]
15. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.
Khan AJ; Man S; Abbas M; Liu S; Zhang F
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130577. PubMed ID: 38301858
[TBL] [Abstract] [Full Text] [Related]
16. Correlation of pten signaling pathway and miRNA in breast cancer.
Mohammadi M; Fazilat A; Mamalo AS; Ojarudi M; Hemmati-Dinarvand M; Beilankouhi EAV; Valilo M
Mol Biol Rep; 2024 Jan; 51(1):221. PubMed ID: 38281224
[TBL] [Abstract] [Full Text] [Related]
17. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with pten hamartoma tumor syndrome.
Liu D; Yehia L; Dhawan A; Ni Y; Eng C
Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.
Ido M; Fujii K; Mishima H; Kubo A; Saito M; Banno H; Ito Y; Goto M; Ando T; Mouri Y; Kousaka J; Imai T; Nakano S
BMC Cancer; 2024 Jan; 24(1):85. PubMed ID: 38229073
[TBL] [Abstract] [Full Text] [Related]
19. Utilizing pten immunohistochemistry as a screening test for Cowden syndrome.
Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
[TBL] [Abstract] [Full Text] [Related]
20. [News in breast oncology genetics for female and male population].
Taris N; Luporsi E; Osada M; Thiblet M; Mathelin C
Gynecol Obstet Fertil Senol; 2024 Mar; 52(3):149-157. PubMed ID: 38190969
[TBL] [Abstract] [Full Text] [Related]
[Next]
